Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share.
-
Shares outstanding
-
10.3M
-
Number of holders
-
9
-
Total shares
-
197K
-
Shares change
-
-656K
-
Total reported value, excl. options
-
$101K
-
Value change
-
-$442K
-
Number of buys
-
5
-
Number of sells
-
-5
-
Price
-
$0.50
Significant Holders of Dermata Therapeutics, Inc. - Common Stock, Par Value $0.0001 Per Share. (DRMA) as of Q3 2022
9 filings reported holding DRMA - Dermata Therapeutics, Inc. - Common Stock, Par Value $0.0001 Per Share. as of Q3 2022.
Dermata Therapeutics, Inc. - Common Stock, Par Value $0.0001 Per Share. (DRMA) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 197K shares
of 10.3M outstanding shares and own 1.91% of the company stock.
Largest 10 shareholders include Virtu Financial LLC (70.8K shares), GEODE CAPITAL MANAGEMENT, LLC (26.7K shares), WELLS FARGO & COMPANY/MN (24.4K shares), JANE STREET GROUP, LLC (23.6K shares), UBS Group AG (14.8K shares), Sage Capital Advisors,llc (12K shares), Tudor Investment Corp Et Al (10.2K shares), FMR LLC (10K shares), Tower Research Capital LLC (TRC) (4.77K shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.